AACR Applauds Release of President’s Cancer Panel Initial Assessment of the National Cancer Plan

PHILADELPHIA — The American Association for Cancer Research (AACR) today issued the following statement regarding the release of the President’s Cancer Panel’s report assessing the National Cancer Institute’s (NCI’s) National Cancer Plan:

“We applaud the President’s Cancer Panel for their comprehensive and thoughtful assessment of the NCI’s National Cancer Plan. The AACR strongly agrees with the Panel’s endorsement of the Plan and looks forward to continuing to support the areas of priority identified in the report. Just yesterday, for example, we hosted the AACR Early-career Hill Day and National Day of Action in support of increasing federal investment in biomedical research.

“We were honored to participate in the September 2023 meeting that helped inform this report, and we are grateful that President Biden and the Administration are staunch champions for collaboration and innovation to address the most pressing challenges in cancer research and treatment. It is only by working together that we will make meaningful progress against cancer for all patients.”

The President’s Cancer Panel, led by Elizabeth M. Jaffee, MD, FAACR, President of the AACR Academy and Past President of the AACR (2018-2019), monitors the development and execution of the activities of the National Cancer Program and reports to the President on progress, efficacy, and opportunities for improvement. The National Cancer Plan, released by the NCI in April 2023, outlines goals that the nation must achieve to prevent cancer, reduce mortality from cancer, and maximize quality of life for people living with cancer. It also provides a set of strategies to accomplish each goal.

Read the Panel’s new report here.